|
Q2 2018
Filed on Jul 30, 2018
|
20,115
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
13,737
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
6,977
|
$48.94 - $49.85
$341K - $348K
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
7,637
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
11,574
|
$24.64 - $25.02
$285K - $290K
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
9,872
|
$28.46 - $31.67
$281K - $313K
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
7,148
|
$52.19 - $52.7
$373K - $377K
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
32,166
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
181,610
|
$50.04 - $50.21
$9.09M - $9.12M
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
16,124
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
11,916
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
6,787
|
$35.9 - $38.25
$244K - $260K
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
28,192
|
$33.22 - $36.21
$937K - $1.02M
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
9,632
|
$24.55 - $26.41
$236K - $254K
|
|
John Hancock Exchange Traded
|
Q2 2018
Filed on Jul 30, 2018
|
26,585
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
18,928
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
25,109
|
$3.8 - $3.97
$95.4K - $99.7K
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
17,101
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
29,971
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
44,087
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
39,001
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
11,525
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
27,655
|
N/A
|
|
Onconova Therapeutics Inc
|
Q2 2018
Filed on Jul 30, 2018
|
17,475
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
13,755
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
23,306
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
14,588
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
10,031
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
5,795
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
10,558
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
28,510
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
14,425
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
11,970
|
$21.51 - $25.72
$257K - $308K
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
15,150
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
6,813
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
14,131
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
13,099
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
54,268
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
7,614
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
26,167
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
14,266
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
14,102
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
20,020
|
$4.58 - $4.81
$91.7K - $96.3K
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
28,348
|
$26.51 - $27.01
$752K - $766K
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
25,428
|
$33.42 - $36.3
$850K - $923K
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
34,886
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
31,227
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
3,040
|
N/A
|
|
Sandridge Mississippian Tr I
|
Q2 2018
Filed on Jul 30, 2018
|
19,300
|
N/A
|
|
|
Q2 2018
Filed on Jul 30, 2018
|
16,187
|
N/A
|
|